Tiger Global Bets on Apollo Global Mgmt (APO); Valeant Pharmaceuticals Intl (VRX) Confirms the Confirmed
Hedge fund firm Tiger Global Management LLC disclosed Friday in a regulatory filing ( SC 13G ) with the Securities and Exchange Commission (SEC) a 7% passive stake (13,063,200 shares) in Apollo Global Management LLC (NYSE:APO).
APO stock closed at $22.99, down $0.19 (or -0.82%) with a total volume of 2.01M shares traded on Friday.
Apollo Global Management, an alternative investment manager in private equity, credit and real estate, has 187.14M shares outstanding, market capitalization (intraday) of $9.37B and APO stock one-year range is from $14.25 to $24.00 per share.
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported after the closing bell Friday in a SEC filing ( Form 8-K ) that billionaire William A. Ackman and Stephen Fraidin informed the company that they do not intend to stand for re-election to the Board at the next annual meeting of stockholders. According to Valeant, their decision comes after Pershing Square Capital Management, L.P. – where they are CEO and Vice Chairman respectively – sold its investment in the Canadian pharmaceutical and medical device company, adding that it was not a result of any disagreement between the parties.
VRX stock finished Friday’s trading session in negative territory by 1.52% (or -$0.17) at $11.03
Valeant Pharmaceuticals International, which develops, manufactures, and markets pharmaceuticals, OTC products, and medical devices worldwide, has 341.19M shares outstanding, market capitalization (intraday) of $3.84B and VRX stock 52-week range is between $10.50 and $38.50 per share.
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/